Abbvie Inc
NYSE:ABBV
Abbvie Inc
Income to Minority Interest
Abbvie Inc
Income to Minority Interest Peer Comparison
Competitive Income to Minority Interest Analysis
Latest Figures & CAGR of Competitors
Company | Income to Minority Interest | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbvie Inc
NYSE:ABBV
|
Income to Minority Interest
-$10m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Income to Minority Interest
$52m
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
11%
|
|
Amgen Inc
NASDAQ:AMGN
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Moderna Inc
NASDAQ:MRNA
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbvie Inc's Income to Minority Interest?
Income to Minority Interest
-10m
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Income to Minority Interest amounts to -10m USD.
What is Abbvie Inc's Income to Minority Interest growth rate?
Income to Minority Interest CAGR 3Y
-19%
Over the last year, the Income to Minority Interest growth was -11%. The average annual Income to Minority Interest growth rates for Abbvie Inc have been -19% over the past three years .